CP
GILD icon

Camelot Portfolios’s Gilead Sciences GILD Stock Holding History

Camelot Portfolios’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-79
Closed -$5.42K – 312
2024
Q2 		$5.42K Buy
+79
New +$5.27K ﹤0.01% 466
2023
Q1 		– Sell
-3,356
Closed -$288K – 188
2022
Q4 		$288K Sell
3,356
-2,261
-40% -$179K 0.21% 132
2022
Q3 		$347K Sell
5,617
-1,597
-22% -$101K 0.33% 93
2022
Q2 		$446K Buy
7,214
+1,849
+34% +$114K 0.27% 113
2022
Q1 		$319K Sell
5,365
-3,356
-38% -$215K 0.16% 167
2021
Q4 		$633K Buy
8,721
+857
+11% +$59K 0.26% 128
2021
Q3 		$549K Sell
7,864
-1,211
-13% -$85.1K 0.28% 107
2021
Q2 		$625K Buy
+9,075
New +$606K 0.25% 120
2016
Q2 		– Sell
-5,815
Closed -$534K – 173
2016
Q1 		$534K Buy
5,815
+3,291
+130% +$297K 0.33% 79
2015
Q4 		$255K Sell
2,524
-45
-2% -$4.68K 0.16% 121
2015
Q3 		$252K Hold
2,569
– – 0.17% 126
2015
Q2 		$301K Buy
2,569
+329
+15% +$36K 0.17% 125
2015
Q1 		$220K Sell
2,240
-5,935
-73% -$603K 0.13% 148
2014
Q4 		$771K Buy
+8,175
New +$845K 0.44% 70

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Camelot Portfolios's GILD Position: Q3 2024 in Review

Camelot Portfolios sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 79 shares — an estimated $5.42K sold.

Camelot Portfolios first reported a position in GILD in Q4 2014 and held it in 14 quarters. The position peaked at $771K in Q4 2014. 1,721 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • Camelot Portfolios reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • Camelot Portfolios sold 79 Gilead Sciences shares in Q3 2024, an estimated $5.42K.
  • Camelot Portfolios first reported a position in Gilead Sciences in Q4 2014 and held it in 14 quarters.
  • Camelot Portfolios's Gilead Sciences position peaked at $771K in Q4 2014.
  • 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Camelot Portfolios's 13F filing for Q3 2024, filed 12 Nov 2024.